4SS-46658-15897

2 vaccinations 9 coded responses 18 check-ins 9 free-text entries 3 call cases

Sex: Female
Age at first dose: 51-55
ZIP prefix: 895 / NV
Registered: 2021-02-24

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-02-05
Dose 1 — Moderna
2021-02-24
Registered in v-safe
2021-02-24
Survey response — day 14, dose 1
MedDRA: Asthma, Chills, Dizziness, Dyspnoea, Fatigue, Injection site erythema, Injection site pain, Pain in extremity, Pre-existing disease — Feeling: Good · Be unable to do your normal daily activities

Free text: Mild symptoms the day after dose 1; fatigue, dizziness, arm pain. Nine days later (2/14) injection site became red/tender, 2 asthma episodes and was short of breath all day, terrible chills (no fever), and very dizzy. Felt fine next day.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-26
Health check-in — day 21, dose 1
Feeling: Good

Adult check-in
2021-03-05
Dose 2 — Moderna
2021-03-05
Health check-in — day 0, dose 2
Feeling: Good · None

Adult check-in
2021-03-06
Health check-in — days 1–6 daily, dose 2
Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2021-03-07
Survey response — days 1–6 daily, dose 2
MedDRA: Dizziness, Dyspnoea — Feeling: Fair · Site: Redness, Swelling, Itching · Headache · Be unable to do your normal daily activities

Free text: Dizzy and short of breath

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-08
Survey response — days 1–6 daily, dose 2
MedDRA: Dyspnoea — Feeling: Fair · Site: Redness, Swelling, Itching · Headache, Fatigue or tiredness · Be unable to do your normal daily activities

Free text: Shortness of breath

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-09
Survey response — days 1–6 daily, dose 2
MedDRA: Dyspnoea — Feeling: Fair · Site: Pain, Itching · Headache · Be unable to do your normal daily activities

Free text: Shortness of breath, moderate

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-10
Survey response — days 1–6 daily, dose 2
MedDRA: Dyspnoea — Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activities

Free text: Short of breath, moderate symptoms

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-11
Survey response — days 1–6 daily, dose 2
MedDRA: Dyspnoea — Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activities

Free text: Short of breath, very mild (improved)

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-14
Survey response — day 7, dose 2
MedDRA: Dyspnoea — Feeling: Fair · Headache · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Short of breath, moderate

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-14
Report sent to call center — day 7, dose 2
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-03-19
Health check-in — day 14, dose 2
Feeling: Fair

Adult check-in
2021-03-26
Health check-in — day 21, dose 2
Feeling: Fair

Adult check-in
2021-04-02
Survey response — day 28, dose 2
MedDRA: Dyspnoea — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

Free text: Shortness of breath persisting since 3/7/2021

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-02
Report sent to call center — day 28, dose 2
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-04-09
Health check-in — day 35, dose 2
Feeling: Fair

Adult check-in
2021-04-16
Health check-in — day 42, dose 2
Feeling: Poor

Adult check-in
2021-06-04
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-06-14
Call successful
Completed over the phone
2021-06-14
Call successful
Completed over the phone
2021-09-03
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2022-03-06
Survey response — 12 months, dose 2
MedDRA: Condition aggravated, Connective tissue disorder, Muscular weakness, Office visit, Pre-existing disease — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Hospitalization

Free text: Symptoms: Autoimmune response as loss of elasticity in ribcage/left lung connective tissue · Healthcare visit (other): Rheumatologist

MedDRA releases: 2024-11 · check-in free text available
2022-03-06
Report sent to call center — 12 months, dose 2
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

Hospitalization · 1 call case(s)
2022-03-07
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-02-05	Moderna
2	2021-03-05	Moderna

Call center

3 call center cases

2 successful · 1 unsuccessful

VAERS report filed, before or during a call: 2

See the call center timeline

Free text

Release 4 — day 14, dose 1

2021-02-24

Symptoms: Mild symptoms the day after dose 1; fatigue, dizziness, arm pain. Nine days later (2/14) injection site became red/tender, 2 asthma episodes and was short of breath all day, terrible chills (no fever), and very dizzy. Felt fine next day.

Release 5 — days 1–6 daily, dose 2

2021-03-07

Systemic reaction (other): Dizzy and short of breath

2021-03-08

Systemic reaction (other): Shortness of breath

2021-03-09

Systemic reaction (other): Shortness of breath, moderate

2021-03-10

Systemic reaction (other): Short of breath, moderate symptoms

2021-03-11

Systemic reaction (other): Short of breath, very mild (improved)

Release 5 — day 7, dose 2

2021-03-14

Systemic reaction (other): Short of breath, moderate

Release 6 — day 28, dose 2

2021-04-02

Symptoms: Shortness of breath persisting since 3/7/2021

Release 11 — 12 months, dose 2

2022-03-06

Symptoms: Autoimmune response as loss of elasticity in ribcage/left lung connective tissue

Healthcare visit (other): Rheumatologist

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
HCVO	Office visit	·	·	✓
SD	Asthma	✓	✓	✓
SD	Chills	✓	✓	✓
SD	Condition aggravated	·	·	✓
SD	Connective tissue disorder	·	·	✓
SD	Dizziness	✓	✓	✓
SD	Dyspnoea	✓	✓	✓
SD	Fatigue	✓	✓	✓
SD	Injection site erythema	✓	✓	✓
SD	Injection site pain	✓	✓	✓
SD	Muscular weakness	·	·	✓
SD	Pain in extremity	✓	✓	✓
SD	Pre-existing disease	✓	✓	✓
SRO	Dizziness	✓	✓	✓
SRO	Dyspnoea	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release